Understanding the Signs: Mastering Uveitis Diagnosis and Treatment Strategies

Understanding the Signs Mastering Uveitis Diagnosis and Treatment Strategies
Media formats available:
Details
Presenters
  • Overview

    During this virtual symposium, retina specialists Sumit Sharma, MD, and Steven Yeh, MD, discuss ways to differentiate among acute, recurrent, and chronic uveitis, as well as available and investigative therapies to treat the condition. Drs. Sharma and Yeh also outline strategies on creating personalized treatment plans for patients with uveitis, based on the latest trial data and their clinical expertise.

    This activity is supported by an unrestricted educational grant from EyePoint Pharmaceuticals.

     

  • Learning Objectives

    Upon completion of this activity, the participant should be able to:

    • Summarize the clinical features of common uveitic presentations including postoperative and localized disease
    • Differentiate between acute, recurrent, and chronic uveitis
    • Describe the pharmacokinetics, safety, and efficacy of sustained-release uveitis treatments on the market and in the pipeline
    • Interpret clinical trial data to create personalized treatment plans for patients with chronic uveitis
    • Accreditation

      Provided by Evolve Medical Education 

      Evolve is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

      Evolve designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

       

    • Participation Method

      In order to obtain credit, proceed through the program, complete the post-test, evaluation and submit for credit.

    • Faculty and Disclosures

      Sumit Sharma, MD

      Sumit Sharma, MD

      Assistant Professor, Ophthalmology
      Cleveland Clinic
      Lerner College of Medicine
      Case Western Reserve University Staff

      in Vitreoretinal Surgery and Uveitis
      Cleveland Clinic Cole Eye Institute
      Cleveland, OH


      Steven Yeh, MD

      Steven Yeh, MD

      Professor and Stanley Truhlsen Jr. 
      Chair in Ophthalmology
      Truhlsen Eye Institute
      University of Nebraska Medical Center
      Omaha, NE
      Adjunct Professor
      Emory University School of Medicine
      Atlanta, GA


      DISCLOSURE POLICY
      It is the policy of Evolve that faculty and other individuals who are in the position to control the content of this activity disclose any real or apparent financial relationships relating to the topics of this educational activity. Evolve has full policies in place that will identify and mitigate all financial relationships prior to this educational activity.

      The following faculty/staff members have the following financial relationships with ineligible companies.

      Sumit Sharma, MD, has had a financial relationship or affiliation with the following ineligible companies in the form of Consultant: AbbVie, Bausch + Lomb, Clearside, EyePoint Pharmaceuticals, Genentech, Regeneron, and RegenxBio. Grant/Research Support: Genentech, Gilead Sciences, Ionis, and Santen.

      Steven Yeh, MD, has had a financial relationship or affiliation with the following ineligible companies in the form of Consultant: Adverum Biotechnologies, Alcon, Bausch + Lomb, EyePoint Pharmaceuticals, and RegenxBio. Grant/Research Support: NIH/NEI and Truhlsen Family Foundation.

      The Evolve staff and planners have no financial relationships with ineligible companies.
      Nisha Mukherjee, MD, peer reviewer, has no financial relationships with ineligible companies.

       

    • Disclaimer

      OFF-LABEL STATEMENT
      This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The opinions expressed in the educational activity are those of the faculty. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

      DISCLAIMER
      The views and opinions expressed in this educational activity are those of the faculty and do not necessarily represent the views of Evolve or EyePoint Pharmaceuticals.
      This activity is designed for educational purposes. Participants have a responsibility to utilize this information to enhance their professional development to improve patient outcomes. Conclusions drawn by the participants should be derived from careful consideration of all available scientific information. The participant should use his/her clinical judgment, knowledge, experience, and diagnostic decision-making before applying any information, whether provided here or by others, for any professional use.

       

    • System Requirements

      • Supported Browsers (2 most recent versions):
        • Google Chrome for Windows, Mac OS, iOS, and Android
        • Apple Safari for Mac OS and iOS
        • Mozilla Firefox for Windows, Mac OS, iOS, and Android
        • Microsoft Edge for Windows
      • Recommended Internet Speed: 5Mbps+

    • Publication Dates

      Release Date:

      Expiration Date:

    Ready to Claim Your Credits?

    You have attempts to pass this post-test. Take your time and review carefully before submitting.

    Good luck!

    Register

    We're glad to see you're enjoying Evolve Medical Education…
    but how about a more personalized experience?

    Register for free